In this week’s Health Tech World Podcast, we talk to Polaroid Therapeutics CEO Ran Frenkel about the company’s promising advancement in the development of superior antimicrobial technology, a revolutionary first in the industry.
The company has achieved a significant pre-clinical milestone in the development of its medical device, which it says will have an immediate and long-lasting effect without causing antimicrobial resistance (AMR).
Listen now on Spotify or your chosen podcast platform.
